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Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2
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The yeast UBC9 gene encodes a protein with homology
to the E2 ubiquitin-conjugating enzymes that mediate
the attachment of ubiquitin to substrate proteins [1].
Depletion of Ubc9p arrests cells in G2 or early M phase
and stabilizes B-type cyclins [1]. p18Ubc9, the Xenopus
homolog of Ubc9p, associates specifically with
p88RanGAP1 and p340RanBP2 [2]. Ran-binding protein 2
(p340RanBP2) is a nuclear pore protein [3,4], and
p88RanGAP1 is a modified form of RanGAP1, a GTPase-
activating protein for the small GTPase Ran [2]. It has
recently been shown that mammalian RanGAP1 can be
conjugated with SUMO-1, a small ubiquitin-related
modifier [5–7], and that SUMO-1 conjugation promotes
RanGAP1’s interaction with RanBP2 [2,5,6]. Here we
show that p18Ubc9 acts as an E2-like enzyme for SUMO-
1 conjugation, but not for ubiquitin conjugation. This
suggests that the SUMO-1 conjugation pathway is
biochemically similar to the ubiquitin conjugation
pathway but uses a distinct set of enzymes and
regulatory mechanisms. We also show that p18Ubc9
interacts specifically with the internal repeat domain of
RanBP2, which is a substrate for SUMO-1 conjugation
in Xenopus egg extracts. 
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Results and discussion
Xenopus RanGAP1 exists in egg extracts in two forms: an
unmodified form (p65RanGAP1) and a modified form
(p88RanGAP1) [2]. Two observations suggest that SUMO-1
conjugation is responsible for the conversion of
p65RanGAP1 to p88RanGAP1 in Xenopus, as it is in mammalian
cells. First, we isolated a Xenopus homolog of SUMO-1
that is highly conserved in comparison with human
SUMO-1 (92% identical, Figure 1a). RNase protection
assays showed the RNA to be ubiquitously expressed
during early frog development (data not shown). This
pattern of expression is consistent with the notion that
SUMO-1 has an important role in nucleocytoplasmic 
trafficking in most cells. 
Second, in vitro analysis indicated that SUMO-1 can be
directly conjugated to Xenopus RanGAP1 (Figure 1b). We
made a series of constructs encoding full-length human
SUMO-1 protein, and two mutants, lacking four (SUMO-
G97) and five (SUMO-G96) amino acids from the carboxyl
terminus. Similar constructs were also made with a glu-
tathione-S-transferase fusion moiety (GST–SUMO-1,
GST–SUMO-G97, GST–SUMO-G96). We expected that
wild-type SUMO-1 would require proteolytic processing
before conjugation, whereas the mutant lacking four
amino acids from its carboxyl terminus could be conju-
gated without processing [8]. We expected that removal of
five amino acids from the carboxyl terminus would yield a
protein that could not undergo conjugation [8]. Consistent
with these expectations, GST–SUMO-G97 and SUMO-
G97 were conjugated to target proteins in both reticulo-
cyte lysates and Xenopus egg extracts (data not shown; see
Figure 1). GST–SUMO-1 and SUMO-1 were processed
and conjugated well only in egg extracts (data not shown),
indicating that reticulocyte lysates lack the activity for the
carboxy-terminal modification of SUMO-1. GST–SUMO-
G96 and SUMO-G96 were not conjugated to target pro-
teins in any of our experiments (data not shown).
When Xenopus RanGAP1 was expressed in a coupled tran-
scription–translation system, two prominent 35S-labeled
bands were observed that co-migrated with p88RanGAP1
and p65RanGAP1 (Figure 1b). When we added GST–ubiq-
uitin, GST–SUMO-1, GST–SUMO-G97 or GST–SUMO-
G96 to the reaction at approximately a 100-fold excess over
the level of endogenous SUMO-1, we found that
GST–SUMO-G97 increased the apparent molecular
weight of the upper band by 30 kDa on SDS–polyacry-
lamide gels (Figure 1b, lane 7). This shift is in good corre-
spondence with the molecular weight of the GST moiety
of the fusion protein, suggesting that GST–SUMO-G97
was able to compete with the endogenous SUMO-1 in
reticulocyte lysates. The addition of excess ubiquitin did
not reverse the shift of Xenopus RanGAP1, indicating that
it did not compete in this reaction (Figure 1b, lane 8). This
experiment confirmed that Xenopus RanGAP1 is subject to
conjugation with SUMO-1 and suggested that SUMO-1
conjugation enzymes are distinct from the enzymes of the
ubiquitin conjugation pathway (see below).
In a different approach, we added 35S-labeled SUMO-1 to
egg extracts and found that it was incorporated into two
major high molecular weight bands, with apparent molec-
ular weights of 88 kDa and 340 kDa. The smaller protein
co-migrated with p88RanGAP1, and both bands were
immunoprecipitated by anti-p340RanBP2 antibodies
(Figure 1c), suggesting that the modified proteins were
p88RanGAP1 and p340RanBP2. On the basis of this observa-
tion and the results discussed below, we believe that
p340RanBP2 is a SUMO-1 conjugation substrate. In this
assay, Xenopus SUMO-1 and human SMT3a [9] behaved
identically to human SUMO-1 (data not shown).
The p18Ubc9 protein associates tightly with p88RanGAP1
and p340RanBP2 in egg extracts [2]. We thus asked
whether p18Ubc9 might act as an E2-like enzyme for
SUMO-1 conjugation. We incubated purified recombi-
nant GST, GST–ubiquitin or each of the three
GST–SUMO fusion proteins in egg extracts. Each of the
proteins and tightly bound extract proteins was purified
using glutathione–Sepharose beads and analyzed by
western blotting with anti-p18Ubc9 antibodies
(Figure 2a). We found no p18Ubc9 associated with GST
or GST–ubiquitin. In contrast, p18Ubc9 was clearly asso-
ciated with GST–SUMO, GST–SUMO-G97 and
GST–SUMO-G96. This observation suggested that
p18Ubc9 has a higher affinity for SUMO-1 than for ubiq-
uitin. To examine whether p18Ubc9 might form a
thioester adduct with SUMO-1, we repeated the same
experiment, omitting reducing agents during sample
preparation. In this case, we observed an additional band
recognized by anti-p18Ubc9 antibodies with an apparent
molecular weight of 60 kDa (Figure 2b). This band was
also recognized by anti-GST antibodies. We believe that
this band is the result of thioester formation between
GST–SUMO-G97 and p18Ubc9, strongly supporting the
idea that p18Ubc9 acts as an E2 conjugating subunit for
SUMO-1. Because Cys93 is analogous to the cysteine
residue of ubiquitin E2 enzymes used for thioester for-
mation, we made a mutant p18Ubc9 with a cysteine to
alanine mutation at residue 93 (p18Ubc9-C93A). This did
not form a thioester adduct with SUMO-1 (data not
shown). This observation suggested that the mechanism
whereby p18Ubc9 acts in SUMO-1 conjugation may be
similar to that of ubiquitin E2 enzymes. 
To confirm the role of p18Ubc9 in the conjugation of
SUMO-1, we immunodepleted p18Ubc9 from Xenopus egg
extracts using affinity-purified antibodies bound to
protein-A–Sepharose beads (Figure 3a). Extracts lacking
p18Ubc9 were deficient in the conjugation of SUMO-1 to
bacterially expressed T7-tagged RanGAP1 (Figure 3b).
The addition of bacterially expressed p18Ubc9 protein
restored the capacity of depleted extracts to conjugate
GST–SUMO-G97 to RanGAP1, demonstrating the speci-
ficity of p18Ubc9 depletion in our experiments. The conju-
gation of SUMO-1 to RanBP2 in egg extracts similarly
required p18Ubc9 (data not shown). These results again
strongly  support the conclusion that p18Ubc9 is an E2 con-
jugating enzyme for SUMO-1.
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Figure 1
SUMO-1 is conjugated to RanGAP1 and
RanBP2/Nup358 in Xenopus laevis.
(a) Xenopus (upper) and human (lower)
SUMO-1. Black dots indicate amino-acid
substitutions. Dash indicates a gap inserted
for sequence alignment. The ubiquitin
homology domain is underlined. Arrowhead
indicates the putative processing site. The
domain structure of SUMO-1 is shown below.
(b) Xenopus RanGAP1 labeled with 35S was
produced in an in vitro transcription–
translation reaction containing exogenous
proteins as indicated. The samples were
subjected to SDS–PAGE and visualized by
autoradiography. Positions of the protein
products detected at 120 kDa, 88 kDa and
65 kDa are shown on the right. (c) SUMO-1
labeled with 35S was produced in reticulocyte
lysates, to which an equal volume of egg
extract was added and incubated for 20 min
at 30°C. 2 µl of the reaction was analyzed
directly by SDS–PAGE (lane 1). 9 µl of the
reaction was subjected to immuno-
precipitation with either preimmune serum
(lane 2) or anti-p340RanBP2 immune serum
(lane 3). Protein products of 340 kDa
(arrowhead), 88 kDa (arrow), unprocessed
SUMO-1 (upper line) and processed 
SUMO-1 (lower line) are indicated.
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Earlier reports have indicated that Ubc9p forms a
thioester with ubiquitin in vitro [1,10]. In our hands,
however, p18Ubc9 interacts exclusively with SUMO-1
rather than with ubiquitin. We therefore believe that
p18Ubc9 functions preferentially as a conjugating enzyme
for SUMO-1, and probably acts in the ubiquitin pathway
with a very low efficiency, if at all. In the absence of
Ubc9p, S. cerevisiae cells arrest at G2/M and are unable to
degrade B-type cyclins [1]. It was originally thought that
Ubc9p might act as an E2 ubiquitin-conjugating enzyme
for cyclins, but it has now been clearly demonstrated that
other proteins fulfill this function [11]. A different model
for Ubc9p function may involve regulation of nuclear
transport. In the absence of Ubc9p, nuclear transport may
arrest and thereby block the destruction of cyclins. The
lack of cyclin destruction may reflect a requirement for
cyclins to interact with nuclear factors in order to be
destroyed. Alternatively, it may reflect an ongoing require-
ment for nuclear trafficking of other components required
for cyclin destruction. 
To better understand the interaction between p18Ubc9
and p340RanBP2, we mapped the subdomains of RanBP2
that interact with p18Ubc9 and the subdomains that are
subject to SUMO-1 conjugation (Figure 4a). We found
co-precipitation of 35S-labeled p18Ubc9 in B7 fragment and
internal repeat (IR) domain immunoprecipitates when
p18Ubc9 was co-expressed with these domains in reticulo-
cyte lysates, but did not see co-precipitation with the
other RanBP2 domains (data not shown; summarized in
Figure 4a). When we translated the RanBP2 domains in
reticulocyte lysates in the presence of [35S]methionine
(Figure 4b), we also noted that translation of the B7 and
IR domains gave a major product of the predicted molecu-
lar weight, as well as additional species that migrated on
SDS–PAGE with a 20 kDa increase in apparent molecular
weight. To determine whether the upper bands could be
SUMO-1 conjugates, we added excess GST–SUMO-G97
to compete with the endogenous protein. The upper
bands in the B7 and IR reactions were shifted to higher
molecular weight species (Figure 4b, white dots). From
these results, we believe that p18Ubc9 associates with the
IR domain of RanBP2 and that this domain of RanBP2 is
subject to SUMO-1 conjugation. Other investigators have
reported SUMO-1 conjugates in mammalian cells, many
with apparent molecular weights above that of p88RanGAP1
[6,8]. However, those proteins have not been identified.
At present, we do not know the functional consequences
of SUMO-1 conjugation of RanBP2. It has been suggested
that RanBP2 may act as a docking site for import sub-
strates and as a scaffold for the assembly of complexes that
coordinate GTP–Ran hydrolysis with the translocation of
substrates into the nucleus [3,4]. If these ideas are correct,
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Figure 2
The p18Ubc9 protein binds and forms a thioester adduct with SUMO-1.
(a) In the presence of reducing agent (+DTT). GST (lanes 1,2),
GST–ubiquitin (lanes 3,4), GST–SUMO-G96 (lanes 5,6),
GST–SUMO-G97 (lanes 7,8) or GST–SUMO-1 (lanes 9,10) were
incubated with phosphate-buffered saline (–) or Xenopus egg extract
(+). GST pull-down assays were performed, and samples were
analyzed by SDS–PAGE and western blotting with anti-p18Ubc9
antibodies. The line indicates p18Ubc9. (b) Samples were prepared as
in (a), but no reducing reagents (–DTT) were added during sample
preparation. The arrowhead indicates the 60 kDa adduct recognized
by anti-p18Ubc9 antibodies.
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Figure 3
The p18Ubc9 protein is essential for SUMO-1 conjugation. (a) Equal
volumes of untreated extract (lane 1), mock-depleted extract (lane 2),
p18Ubc9-depleted extract (lane 3) and p18Ubc9-depleted extracts plus
10 ng/µl recombinant p18Ubc9 (lane 4) were analyzed by western
blotting with anti-p18Ubc9 antibodies. (b) T7-tagged RanGAP1 protein
was conjugated with GST–SUMO-G97 in reactions containing buffer
(lane 1), untreated extract (lane 2), mock-depleted extract (lane 3),
p18Ubc9-depleted extract (lane 4), depleted extract plus recombinant
p18Ubc9 (lane 5) or buffer plus recombinant p18Ubc9 (lane 6). See
Supplementary material for Materials and methods. Conjugation
products were analyzed by western blotting with anti-T7-tag
antibodies. RanGAP1 is indicated by the lines on the right of the panel.
The white dot indicates the GST–SUMO-1-RanGAP1 conjugates.
Similar results were obtained using the B7 fragment (see Figure 4) of
RanBP2.
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conjugation of SUMO-1 to RanBP2 may modulate its
activity and thereby regulate the rate of nuclear transport.
In summary, our results suggest that the SUMO-1 conjuga-
tion pathway is biochemically similar to the ubiquitin con-
jugation pathway, but that it uses a distinct set of enzymes.
Our results also suggest a role for p18Ubc9 in controlling
nuclear transport through p88RanGAP1 and p340RanBP2, and
necessitate the re-evaluation of earlier data regarding the
role of p18Ubc9 in the regulation of mitosis.
Materials and methods
The plasmids used, and methods for the expression of proteins in bac-
teria, protein purification, preparation of Xenopus egg extracts, cDNA
cloning of Xenopus SUMO-1, conjugation assay using GST–SUMO-1,
conjugation assay using [35S]SUMO-1, and the GST pulldown assay
are given in the Supplementary material published with this paper on
the internet.
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Figure 4
The IR domain of RanBP2 is conjugated with
SUMO-1. (a) RanBP2 structure is shown
schematically on the left [3]. In the table, the
left column summarizes which RanBP2
fragments were subject to pull-downs with
GST–SUMO-1; see (b); the right column
summarizes which RanBP2 fragments could
be co-precipitated with p18Ubc9 when they
were co-expressed with p18Ubc9 in
reticulocyte lysates (see text). (b) 35S-labeled
RanBP2 fragments as indicated were
produced in reticulocyte lysates containing
GST (–) or GST–SUMO-G97 (+) (see
Supplementary material for Materials and
methods), and analyzed by SDS–PAGE and
autoradiography. White dots indicate
supershifted B7 and IR products.
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